Is Utah Medical Products, Inc. overvalued?

Utah Medical Products, Inc. (UTMD) looks overvalued — trading about 24% above its fair value.

Overvalued

Price

$71.97

Fair value

$54.73

Current P/E

21.3

Normal P/E

16.2

Market cap

$205.0M

Dividend yield

1.7%

Return on equity

8.8%

Sector

Healthcare

Fair value compares UTMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks